Cynthia lives with Heart Failure with preserved Ejection Fraction, a complex and challenging condition.

Great progress has been made against malaria, but signs of resistance are becoming a rising concern

Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.

A Q&A with Jake Haling, Head of Oncology Drug Discovery in San Diego, on induced proximity and how it could open new paths to treat cancer.

Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

Learn how Novartis researchers are working to outsmart tumors.

Susanne Schaffert, President of Advanced Accelerator Applications, describes her career in science.